FBXO32 and chronic kidney disease: PGC‐1 has also been shown to protect skeletal muscle wasting by suppressing the action of FoxO3 and the expression of atrogin‐1 and MuRF‐1 in rats with chronic renal failure (Sandri et al., 2006).